Curis (CRIS) Tops Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Curis (CRIS) Outpaces in Q3; Roth Affirms 'Buy' Rating Ahead of ASH
November 9, 2015 2:54 PM ESTRoth Capital reaffirms Curis (Nasdaq: CRIS) with a Buy rating and $5 price target following Q3 results and update issued earlier Monday.
Analyst Joseph Pantginis noted that Curis posted Q3 loss of $0.04 per share, versus the firm's outlook calling for a loss of $0.08 per share.
Pantginis continued, INDs for both licensed programs from Aurigene are... More
